Tadalafil improves quality of life and exercise tolerance in idiopathic pulmonary arterial hypertension

Flora Affuso; Emiliano Antonio Palmieri; Pasquale Di Conza; Vincenzo Guardasole; Serafino Fazio

doi:10.1016/j.ijcard.2005.08.051

Tadalafil improves quality of life and exercise tolerance in idiopathic pulmonary arterial hypertension

Int J Cardiol. 2006 Apr 14;108(3):429-31. doi: 10.1016/j.ijcard.2005.08.051. Epub 2005 Nov 2.

Authors

Flora Affuso, Emiliano Antonio Palmieri, Pasquale Di Conza, Vincenzo Guardasole, Serafino Fazio

PMID: 16260051
DOI: 10.1016/j.ijcard.2005.08.051

Abstract

Pulmonary arterial hypertension has a poor prognosis quoad vitam et valitudinem. Herein, we report on a middle-aged woman affected by idiopathic pulmonary arterial hypertension whose quality of life and exercise tolerance improved remarkably after a six-month course of treatment with the long-acting phosphodiesterase-5 inhibitor tadalafil.

Publication types

Case Reports
Letter

MeSH terms

Adult
Carbolines / therapeutic use*
Exercise Tolerance / drug effects*
Female
Hemodynamics
Humans
Hypertension, Pulmonary / drug therapy*
Hypertension, Pulmonary / physiopathology
Oxygen / blood
Phosphodiesterase Inhibitors / therapeutic use*
Quality of Life*
Tadalafil

Substances

Carbolines
Phosphodiesterase Inhibitors
Tadalafil
Oxygen